F.D.A. Did Not Intervene to Curb Risky Fentanyl Prescriptions

Powerful cancer pain drugs were given to patients with other conditions who cannot tolerate them. A program to curb the practice was run by companies that sell the drugs. EMILY BAUMGAERTNER https://ift.tt/2vbKTKb https://ift.tt/2vdC6rd The New York Times Health Opioids and Opiates, Drugs (Pharmaceuticals), Labeling and Labels (Product) August 2, 2018 at 12:00AM